Participants - All
Participant search result
Head of Science and Technology Network
Montreal, Canada
I work at the intersection of science, technology, and policy, unlocking the power of evidence-based innovation to influence and shape effective policymaking.
I work at the intersection of science, technology, and policy, unlocking the power of evidence-based innovation to influence and shape effective policymaking.
I'm Dr. Claudia Penafuerte, CEO and cofounder of Cura Therapeutics, a biotech company developing multimodal immunotherapies for cancer and age-related diseases.
I'm Dr. Claudia Penafuerte, CEO and cofounder of Cura Therapeutics, a biotech company developing multimodal immunotherapies for cancer and age-related diseases.
Co-founder (Ness) building N001: intranasal, virus-agnostic prophylaxis for upper respiratory infections to stop transmission at entry. Seeking EU partners.
Co-founder (Ness) building N001: intranasal, virus-agnostic prophylaxis for upper respiratory infections to stop transmission at entry. Seeking EU partners.
Director, Business Development Medical Devices
Boucherville, Canada
Atlantic Biocorp upcycles Atlantic Canadian fisheries byproducts into premium chitosan and derivatives for high-value, sustainable biomaterials.
Atlantic Biocorp upcycles Atlantic Canadian fisheries byproducts into premium chitosan and derivatives for high-value, sustainable biomaterials.
Industrial Technology Advisor
Oakville, Canada
I will be leading a delegation of Canadian medical biotech companies to the Global Innovation Summit.
I will be leading a delegation of Canadian medical biotech companies to the Global Innovation Summit.
With over 12 years of experience in tissue engineering, she holds a Ph.D. in Mechanical Engineering and is the founder of VoxCell.
With over 12 years of experience in tissue engineering, she holds a Ph.D. in Mechanical Engineering and is the founder of VoxCell.
At Copoly, we are developing blood-based early cancer detection platform OncoSage. We can detect stage I/II lung cancer with 97% sensitivity and 93% specificity
At Copoly, we are developing blood-based early cancer detection platform OncoSage. We can detect stage I/II lung cancer with 97% sensitivity and 93% specificity
A global leader in glycosciences, specializing in advanced glycan synthesis and translational glycobiology to support innovation in medical biotechnology.
A global leader in glycosciences, specializing in advanced glycan synthesis and translational glycobiology to support innovation in medical biotechnology.
Over 25+ years in life sciences driving growth, global partnerships, and innovative solutions. Enthusiastic about next generation vaccine and CGT team building
Over 25+ years in life sciences driving growth, global partnerships, and innovative solutions. Enthusiastic about next generation vaccine and CGT team building
A global leader in glycosciences, specializing in advanced glycan synthesis and translational glycobiology to support innovation in medical biotechnology.
A global leader in glycosciences, specializing in advanced glycan synthesis and translational glycobiology to support innovation in medical biotechnology.
Passionate about translational science - transferring lab findings into technologies that directly benefit the members of our society.
Passionate about translational science - transferring lab findings into technologies that directly benefit the members of our society.
An AI/ML/Genomics specialist developing AI tools such as BioMYND, BioSport, PanOmiQ, BioEMR for diagnosis & treatment and remote monitoring of patients.
An AI/ML/Genomics specialist developing AI tools such as BioMYND, BioSport, PanOmiQ, BioEMR for diagnosis & treatment and remote monitoring of patients.
I'm the CEO of 5 Prime Sciences where we use human genetics and other omics to accelerate our partners' drug development programs.
I'm the CEO of 5 Prime Sciences where we use human genetics and other omics to accelerate our partners' drug development programs.
Head of Business Development
Toronto, Canada
Clinical research professional applying AI to improve trials, patient engagement, and efficiency, exploring AI in cell & gene and health system reform.
Clinical research professional applying AI to improve trials, patient engagement, and efficiency, exploring AI in cell & gene and health system reform.
Dr Jaspreet Grewal is a clinician-investor turning complex science into investable, regulatory-ready opportunities globally.
Dr Jaspreet Grewal is a clinician-investor turning complex science into investable, regulatory-ready opportunities globally.